NWBO NW Biotherapeutics: institutional ownership and insider trading
11 funds reported holding $546K of NW Biotherapeutics in their latest 13F filings; in Q2 2026 funds net bought $112K, with 0 new positions and 0 funds selling out.
Largest institutional holders of NWBO
- COMPASS FINANCIAL MANAGEMENT LLC — $227K
- KELLEHER FINANCIAL ADVISORS — $149K
- Moloney Securities Asset Management, LLC — $128K
- VSM Wealth Advisory, LLC — $15.1K
- Opus Capital Group, LLC — $11.0K
- Ethos Financial Group, LLC — $6.33K
- Williams Jones Wealth Management, LLC. — $4.67K
- AlphaMark Advisors, LLC — $4.00K
- McIlrath & Eck, LLC — $124
- Coston, McIsaac & Partners — $0